| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/23/2009 | WO2008007182A3 Topical pharmaceutical compositions of mupirocin or pharmaceutically acceptable salts or esters thereof |
| 04/23/2009 | WO2007141794A3 Method for treatment of overfiltering and leaking blebs with sterile talc |
| 04/23/2009 | WO2007138577A3 Methods of generating a neural tissue using muscle-derived cells |
| 04/23/2009 | WO2007138574A3 Monitoring responsiveness to and screening for therapeutic compounds that modulat composition and structure of cell membranes |
| 04/23/2009 | WO2007138468A3 Processes for the preparation of lansoprazole |
| 04/23/2009 | WO2007138462A3 Aqueous oral formulations of risperidone |
| 04/23/2009 | WO2007129183A3 Bicyclic heteroaryl compounds as pde10 inhibitors |
| 04/23/2009 | WO2007123511A3 Dosing regimens for the treatment of cancer |
| 04/23/2009 | WO2007116404A3 Cucurbitacin glucosides and use thereof in treating cancer |
| 04/23/2009 | WO2007113830A3 Kit for treating skin infection |
| 04/23/2009 | WO2007102061A3 Prodrugs of benzoquinolizine-2-carboxylic acid |
| 04/23/2009 | WO2007053271A3 In vitro and in vivo anti-inflammatory effects of a sesquiterpene lactone extract from chicory (cichorium intybus l.) |
| 04/23/2009 | WO2007050648A3 Use of tumor necrosis factor- receptor p75 for treatment of ischemia-induced neovascularization |
| 04/23/2009 | WO2007050405A3 The induction of indoleamine 2,3-dioxygenase in dendritic cells by tlr ligands and uses thereof |
| 04/23/2009 | WO2007047811A3 Improved reproductive management |
| 04/23/2009 | WO2007047741A3 Expression of rbap48 in memory and aging and methods related thereto |
| 04/23/2009 | WO2007047394A3 Thiotriazolyl derivatives |
| 04/23/2009 | WO2007046893A3 Methods for generating bioactive assemblies and uses thereof |
| 04/23/2009 | WO2007044902A3 Use of benzyl nicotinate for pain relief |
| 04/23/2009 | WO2007044682A3 Method for treating chronic pain |
| 04/23/2009 | WO2007041213A3 Methods for regulation of p53 translation and function |
| 04/23/2009 | WO2007019373A3 Novel formulations comprising fenofibrate and a statin, and related methods of treatment |
| 04/23/2009 | WO2007016147A3 Topical skin protectant and anti-pruritic compositions |
| 04/23/2009 | WO2007016128A3 Magnesium salt proton pump inhibitor dosage forms |
| 04/23/2009 | WO2007014273A3 Sulfonamides as selective estrogen receptor modulators |
| 04/23/2009 | WO2007014011A3 N-(arylamino)-sulfonamide inhibitors of mek |
| 04/23/2009 | WO2007008588A3 Omeprazole form b |
| 04/23/2009 | WO2007002597A3 Modified-release formulations of a bupropion salt |
| 04/23/2009 | WO2007001448A3 Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals |
| 04/23/2009 | WO2006138453A3 Compositions and methods pertaining to pna synthons and oligomers comprising a universal base |
| 04/23/2009 | WO2006128048A3 Methods and compositions for reducing blood homocysteine levels |
| 04/23/2009 | WO2006127530A3 Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 04/23/2009 | WO2006124913A3 Compositions and methods for the treatment of disorders of the central and peripheral nervous systems |
| 04/23/2009 | WO2006121633A3 Activation of the dax-1 and shp nuclear orphan receptors |
| 04/23/2009 | WO2006121558A3 Method of prevention and treatment of aging, a related disorders and/or age-related manifestations includi r c erosis. |
| 04/23/2009 | WO2006116703A3 Methods and models for stress-induced analgesia |
| 04/23/2009 | WO2006113835A3 Method of stimulating immune response in certain individuals |
| 04/23/2009 | WO2006110642A3 Improved methods of and compositions for the prevention of anxiety, substance abuse, and dependence |
| 04/23/2009 | WO2006110490A3 Agents and methods for osteogenic oxysterols inhibition of oxidative stress on osteogenic cellular differentiation |
| 04/23/2009 | WO2006102308A3 Beta-lactamyl vasopressin v1b antagonists |
| 04/23/2009 | WO2006088824A3 Compounds useful for treating hiv |
| 04/23/2009 | WO2006081192A3 Rnai modulation of the nogo-l or nogo-r gene and uses thereof |
| 04/23/2009 | WO2006071940A3 Enzyme modulators and treatments |
| 04/23/2009 | WO2006066109A3 Hydroxysteroid dehydrogenase inhibitors |
| 04/23/2009 | WO2006055302A3 Method of treating myelodysplastic syndromes |
| 04/23/2009 | WO2006035434A3 Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases |
| 04/23/2009 | WO2006033911A3 Methods of administering water-soluble prodrugs of propofol |
| 04/23/2009 | WO2006029167A3 Treatment of diseases using nalmefene and its analgos |
| 04/23/2009 | WO2006029081A3 Nucleoside-lipid conjugates, their method of preparation and uses thereof |
| 04/23/2009 | WO2006028524A3 Compositions and treatments for inhibiting kinase and/or hmg-coa reductase |
| 04/23/2009 | WO2006001888A3 Compositions and methods for inhibiting angiogenesis |
| 04/23/2009 | WO2005107370A3 Kit for treatment of cancer |
| 04/23/2009 | WO2005099720A3 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis |
| 04/23/2009 | WO2005089443A3 Combinatorial methods and compositions for treatment of melanoma |
| 04/23/2009 | WO2005089067A3 Screening of anti-viral drugs and pharmaceutical compositions containing thiazolidinone derivatives |
| 04/23/2009 | WO2005074375A3 Heparanase inhibitors and uses thereof |
| 04/23/2009 | US20090106852 Influenza Therapeutic |
| 04/23/2009 | US20090105687 Scoring catheter with drug delivery membrane |
| 04/23/2009 | US20090105667 Fluid medication delivery device |
| 04/23/2009 | US20090105632 Electrotransport Of Lisuride |
| 04/23/2009 | US20090105537 Device, System and Method for In-Vivo Examination |
| 04/23/2009 | US20090105478 Novel compounds |
| 04/23/2009 | US20090105471 Macrocyclic compounds as inhibitors of viral replication |
| 04/23/2009 | US20090105351 Micellar drug delivery systems for hydrophobic drugs |
| 04/23/2009 | US20090105350 Process for the preparation of atovaquone |
| 04/23/2009 | US20090105349 alopecia, prostate cancer, livestock growth, acne; use of 4-aryloxybenzonitriles such as 3-Chloro-4-(2-ethylsulfanyl-phenoxy)-benzonitrile or 4-(2,6-Difluoro-phenoxy)-2-trifluoromethyl-benzonitrile |
| 04/23/2009 | US20090105348 Treatment of migraine headaches using antiestrogens |
| 04/23/2009 | US20090105347 Thyronamine derivatives and analogs and methods of use thereof |
| 04/23/2009 | US20090105346 Novel crystalline forms of armodafinil and preparation thereof |
| 04/23/2009 | US20090105345 AMIDE LINKED MODULATORS OF Gamma-SECRETASE |
| 04/23/2009 | US20090105344 Biphenyl carboxylic acids and derivatives thereof |
| 04/23/2009 | US20090105343 Cancer Therapy And Medicaments Therefor |
| 04/23/2009 | US20090105342 Pufa supplements |
| 04/23/2009 | US20090105341 Process for the production of trans-10, cis 12 octadecadienoic acid |
| 04/23/2009 | US20090105340 Composition and/or method for preventing recurrence of stroke |
| 04/23/2009 | US20090105339 Curative drug for neurodegenerative diseases |
| 04/23/2009 | US20090105338 Deuterium-enriched gabexate mesylate |
| 04/23/2009 | US20090105337 Esters of Florfenicol |
| 04/23/2009 | US20090105336 Beneficial Effects of Increasing Local Blood Flow |
| 04/23/2009 | US20090105335 from high glyceride content polyunsaturated oils, including fish oils; saponification of fatty acid with mono or divalent metal hydroxide (potassium, calcium, copper, magnesium); antioxidant stabilizing oil; free flowing; storage stable; nutritional supplement; pet food |
| 04/23/2009 | US20090105334 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| 04/23/2009 | US20090105333 Melatonin agonist treatment |
| 04/23/2009 | US20090105332 Processes of making sesquiterpenoid tashironin, its analogs and their uses |
| 04/23/2009 | US20090105331 Compositions of active ingredients |
| 04/23/2009 | US20090105330 Admixture of carotenoids and isoflavonoids for treating cutaneous symptoms of aging |
| 04/23/2009 | US20090105329 Methods of Treating Cancers with SAHA, Carboplatin, and Paclitaxel and Other Combination Therapies |
| 04/23/2009 | US20090105328 Amino Acid Compounds |
| 04/23/2009 | US20090105327 Dibenzocycloheptane compounds and pharmaceuticals containing these compounds |
| 04/23/2009 | US20090105326 Crystalline Chemotherapeutic |
| 04/23/2009 | US20090105324 Imidazole derivatives for use as edg-1 antagonists |
| 04/23/2009 | US20090105322 Pharmaceutical composition comprising valsartan |
| 04/23/2009 | US20090105321 useful for the treatment of EP4 mediated diseases or conditions, such as acute and chronic pain, osteoarthritis, rheumatoid arthritis, cancer and glaucoma; 4-[(1S)-1-({[1-(3-chlorobenzyl)-2,3-dihydro-1H-indol-7-yl]carbonyl}amino)ethyl]benzoic acid |
| 04/23/2009 | US20090105319 Naphthalene-based inhibitors of anti-apoptotic proteins |
| 04/23/2009 | US20090105318 Amidoethylthioether Orexin Receptor Antagonists |
| 04/23/2009 | US20090105317 VEGF Inhibition |
| 04/23/2009 | US20090105315 Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as s1p receptor agonists |
| 04/23/2009 | US20090105314 Pharmaceutical Agent |
| 04/23/2009 | US20090105313 Preventive or therapeutic agent for keratoconjunctival disorder |
| 04/23/2009 | US20090105312 Solid preparation having improved solubility |
| 04/23/2009 | US20090105310 Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds and Methods of Use |